Designing Evidence That Pays: Aligning Value Between Innovators and Payers

As payers and pharma raise the bar for real-world evidence, digital health and virtual care innovators face mounting pressure to prove both clinical and economic impact. Evidence is no longer just about demonstrating efficacy — it’s about translating outcomes into payment, partnerships, and sustainable business models. This masterclass convenes leaders from across payers, pharma, and digital health to unpack how evidence expectations are evolving and how collaboration can close the gap between innovation and reimbursement.

Participants will explore frameworks for building data sets that meet payer standards, design pragmatic studies aligned with reimbursement priorities, and structure value narratives that resonate with both clinical and financial decision-makers. The discussion will surface practical insights on co-developing studies, engaging early with payer partners, and designing for the evidence thresholds that unlock scalable adoption.

Join us to discuss:

• How are payers and pharma redefining the evidence standards that determine coverage and payment for digital health?

• What frameworks best quantify digital tools’ clinical and economic impact?

• How can innovators and payers collaborate earlier to ensure evidence translates into reimbursement, not just recognition?